DIABOLODBT and ACT Combined Program for Suicidal Behavior Prevention in BPD Patients
DBT+ACT
+ DBT
Mental Disorders
+ Borderline Personality Disorder
+ Personality Disorders
Prevention Study
Summary
Study start date: November 30, 2019
Actual date on which the first participant was enrolled.This study is about finding a better way to prevent suicidal behavior in women with Borderline Personality Disorder (BPD). BPD is a condition where a person has trouble managing their emotions, often leading to suicidal thoughts. The study combines two therapies, Dialectical Behavior Therapy (DBT) and Acceptance Commitment Therapy (ACT), to help these women. DBT teaches skills in areas like managing emotions and dealing with stress, while ACT helps develop thinking skills and understanding what's important in life. The goal is to see if combining these therapies can reduce suicidal behavior, improve quality of life, and lower costs related to BPD care. Women participating in the study will have 4 visits. The first visit is for inclusion, happening 1 or 2 weeks before therapy starts, involving a clinical exam and questionnaires. The next three visits are follow-ups, happening at 6, 12, and 18 months after the first therapy session for the group receiving both DBT and ACT. These visits involve clinical exams, questionnaires, and evaluations of the therapy's effectiveness and satisfaction. The main outcome measured is the number of suicide attempts before and after therapy, using the Columbia-Suicide Severity Rating Scale.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Prevention Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Female
Biological sex of participants that are eligible to enroll.From 18 to 50 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location